Your Integrated Pathology Research Organisation

Pathology plays a decisive role in translational research and clinical trials, yet it is often a source of inconsistency, delay and uncertainty. Multiple vendors, variable scoring and limited access to subspecialist expertise can undermine data quality, slow down timelines and add regulatory risk. In fact, the majority of translational programmes fail to progress to trials, and nearly 90% of clinical trial drugs never reach approval. Watch this webinar to learn how expert-led, digitally enabled pathology can turn these challenges into opportunities for sponsors and CROs.